136 related articles for article (PubMed ID: 21931082)
1. T.M.I. (Too much information)?
Udelson JE
Circulation; 2011 Oct; 124(16):1697-9. PubMed ID: 21931082
[No Abstract] [Full Text] [Related]
2. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
[TBL] [Abstract][Full Text] [Related]
3. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.
Suzuki H; Nodera M; Kamioka M; Kaneshiro T; Kamiyama Y; Takeishi Y
Heart Vessels; 2017 Aug; 32(8):926-931. PubMed ID: 28181011
[TBL] [Abstract][Full Text] [Related]
4. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ; ;
Eur J Heart Fail; 2010 Nov; 12(11):1143-53. PubMed ID: 20965877
[No Abstract] [Full Text] [Related]
5. Implantable cardiovascular sensors and computers: interventional heart failure strategies.
Smith SA; Abraham WT
Curr Cardiol Rep; 2012 Oct; 14(5):611-8. PubMed ID: 22814631
[TBL] [Abstract][Full Text] [Related]
6. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
[TBL] [Abstract][Full Text] [Related]
7. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
Sullivan RM; Olshansky B
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
[No Abstract] [Full Text] [Related]
8. Intrathoracic impedance monitoring in patients with heart failure: correlation with dehydration and bleeding events.
Asada K; Fujiu K; Imai Y; Kojima T; Sugiyama H; Suzuki T; Kinugawa K; Hirata Y; Nagai R
Circ J; 2012; 76(11):2592-8. PubMed ID: 22813787
[TBL] [Abstract][Full Text] [Related]
9. [Quality improvement in Germany: a way to better electrophysiology?].
Israel CW
Herzschrittmacherther Elektrophysiol; 2010 Sep; 21(3):151-2. PubMed ID: 20821334
[No Abstract] [Full Text] [Related]
10. Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.
Fung JW; Yu CM
Curr Heart Fail Rep; 2007 Mar; 4(1):48-52. PubMed ID: 17386186
[TBL] [Abstract][Full Text] [Related]
11. Nonsurgical therapy for heart failure.
Park KW
Int Anesthesiol Clin; 2012; 50(3):1-21. PubMed ID: 22735717
[No Abstract] [Full Text] [Related]
12. Detection of heart failure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator.
Lüthje L; Drescher T; Zenker D; Vollmann D
Heart Rhythm; 2005 Sep; 2(9):997-9. PubMed ID: 16171758
[No Abstract] [Full Text] [Related]
13. Errata: The Usefulness and Limitations of Impedance Cardiography for Cardiac Resynchronization Therapy Device Optimization.
Int Heart J; 2023; 64(2):330. PubMed ID: 37005326
[TBL] [Abstract][Full Text] [Related]
14. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
Poole JE
Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
[No Abstract] [Full Text] [Related]
15. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
[TBL] [Abstract][Full Text] [Related]
16. 'False-positive' intrathoracic impedance monitor alarm caused by amiodarone-induced hypothyroidism in a patient with cardiac resynchronization therapy-defibrillator.
Nakashima T; Takasugi N; Kubota T; Takasugi M; Kanamori H; Ushikoshi H; Hattori A; Aoyama T; Kawasaki M; Nishigaki K; Takemura G; Minatoguchi S
Europace; 2012 May; 14(5):768-9. PubMed ID: 22158828
[No Abstract] [Full Text] [Related]
17. Device therapy in heart failure patients with chronic kidney disease.
Cannizzaro LA; Piccini JP; Patel UD; Hernandez AF
J Am Coll Cardiol; 2011 Aug; 58(9):889-96. PubMed ID: 21851875
[TBL] [Abstract][Full Text] [Related]
18. Impedance cardiography: a useful and reliable tool in optimization of cardiac resynchronization devices.
Heinroth KM; Elster M; Nuding S; Schlegel F; Christoph A; Carter J; Buerke M; Werdan K
Europace; 2007 Sep; 9(9):744-50. PubMed ID: 17496288
[TBL] [Abstract][Full Text] [Related]
19. Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator: a pilot study.
Zabarovskaja S; Gadler F; Gabrielsen A; Linde C; Lund LH
J Heart Lung Transplant; 2013 Jun; 32(6):651-4. PubMed ID: 23701855
[No Abstract] [Full Text] [Related]
20. Deterioration from improved heart failure status in a recipient of a cardiac resynchronization therapy-defibrillator (CRT-D) following a single inappropriate shock.
Kantharia BK
Int J Cardiol; 2012 Nov; 161(3):e55-7. PubMed ID: 22546544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
